Scarica l'app Stockscreener
4.95
3.51%
-0.18
Dopo l'orario di chiusura:
4.97
0.02
+0.40%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Precedente Chiudi:
$5.13
Aprire:
$5.18
Volume 24 ore:
5.32M
Relative Volume:
1.17
Capitalizzazione di mercato:
$1.12B
Reddito:
-
Utile/perdita netta:
$-283.26M
Rapporto P/E:
-3.3673
EPS:
-1.47
Flusso di cassa netto:
$-273.61M
1 W Prestazione:
+6.91%
1M Prestazione:
+70.69%
6M Prestazione:
+46.45%
1 anno Prestazione:
-18.18%
Intervallo 1D:
$4.715
$5.20
Intervallo di 1 settimana:
$4.165
$5.33
Portata 52W:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
Nome
Sana Biotechnology Inc
Settore
Industria
Telefono
(206) 701-7914
Indirizzo
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Confronta SANA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
4.95 | 1.16B | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-03-18 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Iniziato | Jefferies | Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-11-05 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Iniziato | Rodman & Renshaw | Buy |
| 2024-01-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-05 | Iniziato | Citigroup | Buy |
| 2023-08-14 | Iniziato | TD Cowen | Market Perform |
| 2023-05-02 | Iniziato | H.C. Wainwright | Neutral |
| 2021-03-01 | Iniziato | BofA Securities | Buy |
| 2021-03-01 | Iniziato | Goldman | Neutral |
| 2021-03-01 | Iniziato | JP Morgan | Neutral |
| 2021-03-01 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Is Sana Biotechnology Inc. a good long term investmentSuperior capital gains - PrintWeekIndia
What drives Sana Biotechnology Inc. stock priceConsistently profitable trades - Autocar Professional
When is the best time to buy Sana Biotechnology Inc. stockFree Stock Market Forecast Reports - jammulinksnews.com
What analysts say about Sana Biotechnology Inc. stockExceptional risk-adjusted gains - Autocar Professional
Citi Maintained a Buy Rating on Sana Biotechnology (SANA) - MSN
Sana Biotechnology Inc. Stock Analysis and ForecastHigh-velocity capital appreciation - jammulinksnews.com
11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey
Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results - MSN
Commit To Purchase Sana Biotechnology At $2.50, Earn 28% Using Options - Nasdaq
Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors - GlobeNewswire Inc.
How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes - Benzinga
Sana Biotechnology, Inc. (SANA) Secures an Overweight Rating from Morgan Stanley - MSN
Sana Biotechnology: A Stem Cell Breakthrough at the Crossroads of Risk and Reward - AInvest
Sana Biotechnology (SANA) Soars 4.11% on Positive Diabetes Data - AInvest
Sana Reports Promising Diabetes Cell Therapy Data at ADA Meeting - MSN
Sana Biotechnology’s SWOT analysis: innovative cell therapy stock faces challenges By Investing.com - Investing.com South Africa
Sana Biotechnology’s SWOT analysis: innovative cell therapy stock faces challenges - Investing.com
Sana Biotechnology's 9% Spike: Technical Signals and Peer Dynamics Drive Unusual Intraday Rally - AInvest
Sana Biotechnology (SANA.O) Surges 9% Amid Technical Bullish Signal: What’s Driving the Move? - AInvest
Sana Biotechnology's 9% Surge: Technical Bullishness or Biotech Momentum? - AInvest
Sana Biotechnology's 9% Surge: Technical Bullish Signal or Sector Shift? - AInvest
Sana Biotechnology’s 9% Surge: Technical Catalysts and Peer Dynamics - AInvest
Sana Biotechnology's 9% Surge: Technicals or a Hidden Catalyst? - AInvest
Sana Biotechnology's 9% Spike: A Technical Catalyst Amid Mixed Biotech Sentiment - AInvest
Sana Biotechnology's 9% Surge: Technical Catalysts and Market Dynamics - AInvest
Morgan Stanley Assigns Overweight Rating to Sana Biotechnology with $12 Price Target - AInvest
Sana Biotechnology assumed with an Overweight at Morgan Stanley - TipRanks
Top 10 CRISPR Stocks to Buy Now - Insider Monkey
Sana Biotechnology, Inc.(NasdaqGS: SANA) added to Russell 3000E Value Index - MarketScreener
Sana Biotechnology (SANA) Receives a Buy from Citizens JMP - The Globe and Mail
BofA Remains Bullish on Sana Biotechnology (SANA) - MSN
Sana Biotechnology Inc Azioni (SANA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):